Comparative Pharmacology
Head-to-head clinical analysis: DIPYRIDAMOLE versus MEPROBAMATE AND ASPIRIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIPYRIDAMOLE versus MEPROBAMATE AND ASPIRIN.
DIPYRIDAMOLE vs MEPROBAMATE AND ASPIRIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits platelet phosphodiesterase and blocks adenosine reuptake, increasing intracellular cAMP and adenosine levels, thereby inhibiting platelet aggregation; also causes coronary vasodilation.
Meprobamate is a carbamate derivative that acts as a CNS depressant, potentiating GABA-A receptor activity and inhibiting polysynaptic spinal reflexes. Aspirin irreversibly acetylates cyclooxygenase-1 and -2 (COX-1/2), inhibiting prostaglandin and thromboxane synthesis, resulting in analgesic, antipyretic, anti-inflammatory, and antiplatelet effects.
Dipyridamole immediate-release tablets: 50-100 mg orally 3-4 times daily. Extended-release with aspirin: 200 mg orally twice daily.
Aspirin 325 mg and meprobamate 200 mg orally every 6 to 8 hours as needed for pain or anxiety. Maximum daily dose: aspirin 3.9 g, meprobamate 1.6 g.
None Documented
None Documented
Clinical Note
moderateDipyridamole + Tranilast
"Dipyridamole may increase the anticoagulant activities of Tranilast."
Clinical Note
moderateDipyridamole + Resveratrol
"Dipyridamole may increase the anticoagulant activities of Resveratrol."
Clinical Note
moderateDipyridamole + Nimesulide
"Dipyridamole may increase the anticoagulant activities of Nimesulide."
Clinical Note
moderateDipyridamole + Hydrochlorothiazide
"The risk or severity of adverse effects can be increased when Dipyridamole is combined with Hydrochlorothiazide."
Terminal elimination half-life is 10–12 hours in healthy adults; prolonged to 20–30 hours in hepatic impairment; clinical effect duration correlates with dosing interval.
Aspirin: 15-20 minutes (parent drug), but salicylate half-life is dose-dependent: 2-3 hours for low doses, 15-30 hours for high doses. Meprobamate: 6-17 hours (mean 10 hours), prolonged in overdose or hepatic impairment.
Primarily hepatic metabolism (glucuronidation) with enterohepatic recirculation; biliary/fecal excretion accounts for >90% of eliminated drug; renal excretion of unchanged drug is negligible (<5%).
Aspirin: Renal excretion of salicylates (75% as salicyluric acid, 10% as salicylic acid, 10% as phenolic glucuronide, 5% as acyl glucuronide). Meprobamate: Renal excretion (10-20% unchanged, 80-90% as hydroxylated metabolites) and biliary excretion (<5%).
Category A/B
Category D/X
Antiplatelet
NSAID / Antiplatelet